Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of bone marker feedback on adherence to once-monthly ibandronate in postmenopausal osteoporosis
2005-005399-34Phase 4Completed
- Sponsor
- Roche
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ibandronic acid in osteoporosis (2 arms), sponsored by Roche. Primary endpoint: Primary adherence endpoint. Started Dec 2005; status: completed.
02
Drugs
ibandronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2005-005399-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005399-34.